Kraig Biocraft Laboratories' Spider Silk Production Poised to Double
May 29 2014 - 6:05AM
Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the
leading developer of advanced spider silk based fibers, announced
that its production evaluation team reported that the Company's
genetically engineered spider silk, Monster Silk™, production
program is thriving and is successfully accommodating a recent
significant increase in the scale of production.
The Company previously reported that its pilot production
program's viable silk cocoon yield rate was at approximately 30%,
in late 2013. By March, after launching the commercial production
ramp up program, the yields increased to approximately 70%; more
than double the output efficiency from the pilot phase.
The latest report is that with the increased scale of
operations in May, the high yields appear to be holding, and
possibly improving even further.
The Company believes that the high yield is a result of a
combination of improved production procedures and
adaptability. The Company is ordering a further doubling of
production in June.
"We always believed that our scientific model would translate
very well into real world environments, but to actually see our
silkworms perform at this level is inspiring. The technology
is now outperforming the infrastructural capacities, which bodes
well for future product, and production, expansion," said Company
Founder and CEO, Kim K. Thompson.
"The fact that the reported yield rates are holding, or
improving, has given us the confidence to authorize a doubling of
the scale of production. We anticipate this next larger production
run will launch in June. We are excited and encouraged to see
that our systems are holding up well as we increase the scale of
Monster Silk™ production, and we are working with third parties to
strengthen the infrastructure to support the increased production,"
Thompson concluded.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully
reporting biotechnology company is the leading developer of
genetically engineered spider silk based fiber technologies. The
Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global
textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "estimated," "hopes," "if," "develops," "researching,"
"research," "pilot," "potential," "could" or other words or phrases
of similar import. Forward looking statements include descriptions
of the Company's business strategy, outlook, objectives, plans,
intentions and goals. All such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those in forward-looking
statements.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Apr 2023 to Apr 2024